Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure

The American Journal of Pathology - Tập 186 - Trang 312-323 - 2016
Matthew McMillin1,2,3, Gabriel Frampton1,2,3, Matthew Quinn1,4, Samir Ashfaq2, Mario de los Santos2, Stephanie Grant1,2,3, Sharon DeMorrow1,2,3
1Department of Internal Medicine, Texas A&M Health Science Center, College of Medicine, Temple, Texas
2Digestive Disease Research Center, Baylor Scott & White Health, Temple, Texas
3Central Texas Veterans Healthcare System, Temple, Texas
4Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina

Tài liệu tham khảo

Butterworth, 2011, Hepatic encephalopathy: a central neuroinflammatory disorder?, Hepatology, 53, 1372, 10.1002/hep.24228 Hazell, 1999, Hepatic encephalopathy: an update of pathophysiologic mechanisms, Proc Soc Exp Biol Med, 222, 99, 10.1046/j.1525-1373.1999.d01-120.x Kramer, 2011, Detoxification as a treatment goal in hepatic failure, Liver Int, 31 Suppl 3, 1, 10.1111/j.1478-3231.2011.02587.x Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med, 137, 947, 10.7326/0003-4819-137-12-200212170-00007 St-Pierre, 2001, Transport of bile acids in hepatic and non-hepatic tissues, J Exp Biol, 204, 1673, 10.1242/jeb.204.10.1673 Dawson, 2011, Role of the intestinal bile acid transporters in bile acid and drug disposition, Handb Exp Pharmacol, 201, 169, 10.1007/978-3-642-14541-4_4 Redinger, 2003, The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: bile salts as ligands for nuclear hormone receptors, Can J Gastroenterol, 17, 265, 10.1155/2003/190784 Rizzo, 2005, Role of FXR in regulating bile acid homeostasis and relevance for human diseases, Curr Drug Targets Immune Endocr Metabol Disord, 5, 289, 10.2174/1568008054863781 Greim, 1972, Mechanism of cholestasis, 6: bile acids in human livers with or without biliary obstruction, Gastroenterology, 63, 846, 10.1016/S0016-5085(19)33226-3 Greim, 1972, Mechanism of cholestasis, 5: bile acids in normal rat livers and in those after bile duct ligation, Gastroenterology, 63, 837, 10.1016/S0016-5085(19)33225-1 Muriel, 1997, Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats, Pharmacology, 54, 179, 10.1159/000139485 Raiford, 1995, Pruritus of chronic cholestasis, QJM, 88, 603 Ma, 1997, Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy, J Hepatol, 26, 904, 10.1016/S0168-8278(97)80259-0 Bomzon, 1995, Bile acids as endogenous vasodilators?, Biochem Pharmacol, 49, 581, 10.1016/0006-2952(94)00428-O Shneider, 1995, Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter, J Clin Invest, 95, 745, 10.1172/JCI117722 Erickson, 2003, Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice, J Lipid Res, 44, 1001, 10.1194/jlr.M200489-JLR200 McMillin, 2014, Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice, J Hepatol, 61, 1260, 10.1016/j.jhep.2014.07.015 McMillin, 2014, Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline, J Neuroinflammation, 11, 121, 10.1186/1742-2094-11-121 McMillin, 2015, TGR5 signaling reduces neuroinflammation during hepatic encephalopathy, J Neurochem, 135, 565, 10.1111/jnc.13243 Baskaya, 2000, Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury, J Neurosurg, 92, 448, 10.3171/jns.2000.92.3.0448 Cao, 2012, Hypertonic saline reduces lipopolysaccharide-induced mouse brain edema through inhibiting aquaporin 4 expression, Crit Care, 16, R186, 10.1186/cc11670 Bemeur, 2010, N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms, Metab Brain Dis, 25, 241, 10.1007/s11011-010-9201-2 Zhang, 2010, Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice, J Lipid Res, 51, 3230, 10.1194/jlr.M007641 Mills, 1991, Cholyl-lysylfluorescein: synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver, Biochim Biophys Acta, 1115, 151, 10.1016/0304-4165(91)90024-B de Waart, 2010, Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein, J Pharmacol Exp Ther, 334, 78, 10.1124/jpet.110.166991 Quinn, 2014, Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms, Dig Liver Dis, 46, 527, 10.1016/j.dld.2014.01.159 Frampton, 2010, Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling, Exp Cell Res, 316, 1465, 10.1016/j.yexcr.2010.03.017 DeMorrow, 2007, Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts, J Biol Chem, 282, 13098, 10.1074/jbc.M608238200 Goodenough, 1997, Immediate early gene expression and delayed cell death in limbic areas of the rat brain after kainic acid treatment and recovery in the cold, Exp Neurol, 145, 451, 10.1006/exnr.1997.6471 Frampton, 2012, Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism, Gut, 61, 268, 10.1136/gutjnl-2011-300643 DeMorrow, 2008, The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway, Am J Physiol Gastrointest Liver Physiol, 295, G1150, 10.1152/ajpgi.90455.2008 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Goodenough, 2000, Cell death and immunohistochemistry of p53, c-Fos and c-Jun after spermine injection into the rat striatum, Exp Brain Res, 131, 126, 10.1007/s002219900254 Cash, 2010, Current concepts in the assessment and treatment of hepatic encephalopathy, QJM, 103, 9, 10.1093/qjmed/hcp152 Hori, 2011, Fulminant liver failure model with hepatic encephalopathy in the mouse, Ann Gastroenterol, 24, 294 Jayakumar, 2013, Brain edema in acute liver failure: role of neurosteroids, Arch Biochem Biophys, 536, 171, 10.1016/j.abb.2013.03.007 McMillin, 2015, TGFbeta1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5, Lab Invest, 95, 903, 10.1038/labinvest.2015.70 Nguyen, 2006, Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice, J Hepatol, 44, 1105, 10.1016/j.jhep.2005.09.019 Chastre, 2014, Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure, Liver Int, 34, 353, 10.1111/liv.12252 Butterworth, 2013, The liver-brain axis in liver failure: neuroinflammation and encephalopathy, Nat Rev Gastroenterol Hepatol, 10, 522, 10.1038/nrgastro.2013.99 Bemeur, 2010, IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure, Neurochem Int, 56, 213, 10.1016/j.neuint.2009.11.010 Matkowskyj, 1999, Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model, Am J Physiol, 277, G455 Kakiyama, 2013, Modulation of the fecal bile acid profile by gut microbiota in cirrhosis, J Hepatol, 58, 949, 10.1016/j.jhep.2013.01.003 Bron, 1977, Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure, Gut, 18, 692, 10.1136/gut.18.9.692 Tripodi, 2012, Bile acids content in brain of common duct ligated rats, Ann Hepatol, 11, 930, 10.1016/S1665-2681(19)31420-6 Choi, 2013, Acute hepatic encephalopathy presenting as cortical laminar necrosis: case report, Korean J Radiol, 14, 324, 10.3348/kjr.2013.14.2.324 Arnold, 2001, Acute hepatic encephalopathy with diffuse cortical lesions, Neuroradiology, 43, 551, 10.1007/s002340000461 Matsusue, 2005, Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations, AJNR Am J Neuroradiol, 26, 347 Kremer, 2008, Pathogenesis and treatment of pruritus in cholestasis, Drugs, 68, 2163, 10.2165/00003495-200868150-00006 Scaldaferri, 2013, Use and indications of cholestyramine and bile acid sequestrants, Intern Emerg Med, 8, 205, 10.1007/s11739-011-0653-0 Bhushan, 2013, Role of bile acids in liver injury and regeneration following acetaminophen overdose, Am J Pathol, 183, 1518, 10.1016/j.ajpath.2013.07.012 Choudhuri, 2003, Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats, Drug Metab Dispos, 31, 1337, 10.1124/dmd.31.11.1337 Chen, 2009, Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure, Hepatology, 50, 1914, 10.1002/hep.23203 Faropoulos, 2010, Altered occludin expression in brain capillaries induced by obstructive jaundice in rats, Brain Res, 1325, 121, 10.1016/j.brainres.2010.02.020 Shimojima, 2008, Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure, J Invest Surg, 21, 101, 10.1080/08941930802043565 Wright, 2007, Endotoxemia produces coma and brain swelling in bile duct ligated rats, Hepatology, 45, 1517, 10.1002/hep.21599 Keitel, 2010, The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain, Glia, 58, 1794, 10.1002/glia.21049 Belanger, 2006, Neurobiological characterization of an azoxymethane mouse model of acute liver failure, Neurochem Int, 48, 434, 10.1016/j.neuint.2005.11.022